04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/11/2025
7:00 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
6:06 AM | iTeos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2025
6:14 AM | iTeos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
6:10 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
5:00 PM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
7:27 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G | |
11/19/2024
6:59 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ITOS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for iTeos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/19/2024
8:57 AM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
11/18/2024
8:57 PM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
11/14/2024
5:04 PM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
8:49 PM | Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
10/15/2024
6:20 PM | Boxer Asset Management Inc. (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
09/30/2024
8:00 AM | iTeos Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
09/16/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:00 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
6:16 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2024
6:19 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Iannone Robert (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
RHOADS ANN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Hallal David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Ho Tony W (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:01 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:37 AM | Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
05/14/2024
8:32 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
8:06 PM | iTeos Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
8:10 PM | iTeos Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
05/13/2024
6:01 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
3:35 PM | iTeos Therapeutics (Filer)
| Form 424B5 | |
05/10/2024
7:31 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
6:13 AM | iTeos Therapeutics (Filer)
| Form ARS | |
BREAKING: Trump Bans NVIDIA Chips to China (Ad) On April 16th, 2025, President Trump banned Nvidia from selling its most advanced semiconductors to China.
That brings the U.S. and China closer to war than at any time since the Korean War ended in 1953. There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K, |
04/25/2024
6:03 AM | iTeos Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
6:07 AM | iTeos Therapeutics (Filer)
| Form DEFA14A | |
